News
EW
69.29
+1.97%
1.34
Abbott Laboratories Basking In A Sharp Turn In Sentiment
Seeking Alpha · 1d ago
After Hours Most Active for Mar 13, 2025 : HTZ, NVDA, HOOD, TD, HPE, PRMB, AVGO, AAPL, BAM, SLF, EW, TSLA
NASDAQ · 4d ago
Insider Sale: CEO of $EW Sells 6,164 Shares
NASDAQ · 03/10 23:45
Weekly Report: what happened at EW last week (0303-0307)?
Weekly Report · 03/10 09:03
Dividend ‘hopefuls’ – stocks have the ability to pay dividends but don't
Seeking Alpha · 03/07 19:10
Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St · 03/05 10:20
Edwards Lifesciences To Present At TD Cowen Health Care Conference; Webcast At 9:50 AM ET
NASDAQ · 03/04 13:54
Stocks that could be safe from tariffs risk compared to their industry peers
Seeking Alpha · 03/03 19:16
Weekly Report: what happened at EW last week (0224-0228)?
Weekly Report · 03/03 09:03
EDWARDS LIFESCIENCES CORPORATION Form 10-K Annual Report—2024
Press release · 02/28 22:46
At US$71.45, Is It Time To Put Edwards Lifesciences Corporation (NYSE:EW) On Your Watch List?
Simply Wall St · 02/26 16:01
A Look Into Edwards Lifesciences Inc's Price Over Earnings
Benzinga · 02/26 13:45
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
Barchart · 02/25 06:05
Hartford Healthcare Fund Q4 2024 Commentary
Seeking Alpha · 02/25 02:43
Weekly Report: what happened at EW last week (0217-0221)?
Weekly Report · 02/24 09:03
EDWARDS LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
PR Newswire · 02/22 03:50
Harbor Capital Appreciation Fund Q4 2024 Commentary
Seeking Alpha · 02/20 13:05
BNY Mellon Global Stock Fund Q4 2024 Commentary
Seeking Alpha · 02/19 19:23
Peering Into Edwards Lifesciences's Recent Short Interest
Benzinga · 02/18 20:15
Weekly Report: what happened at EW last week (0210-0214)?
Weekly Report · 02/17 09:03
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
More
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.